Extraction, Chemical Composition, Antioxidant Property, andIn-vitroAnticancer Activity of Silymarin fromSilybum marianumon Kb and A549 Cell Lines / Mojgan Azadpour, Mohammad Morad Farajollahi, Ali Mohammad Varzi, Pejman Hashemzadeh, Hossein Mahmoudvand, Mitra Barati
Introduction: This study aimed to evaluate the antioxidant property of Silymarin (SM) extracted from the seed of Silybum marianum and its anticancer activity on KB and A549 cell lines following 24, 48, and 72 h of treatment. Methods: Ten grams of powdered S. marianum seeds were defatted using n-hexane for 6 hours and then extracted by methanol. The Silymarin extracted of extraction components. The extracted components of Silymarin were measured by spectrophotometric assay and HPLC analysis. 2, 2- diphenyl-1-picrylhydrazyl (DPPH) radical scavenging, phenol content, total flavonoid content, and total antioxidant capacity were measured to detect the antioxidant properties of SM. The anticancer activity of the SM on cell lines evaluated by MTT. Results: In HPLC analysis, more than 50% of the peaks were related to silybin A and B. SM was reduced DPPH (the stable free radical) with a 50% inhibitory concentration (IC50) of 6.56 μg/ ml in comparison with butylated hydroxyl toluene (BHT), which indicated an IC50 of ~3.9 μg/ ml. The cytotoxicity effect of SM on the cell lines was studied by MTT assay. The cytotoxicity effect of the extracted Silymarin on KB and A549 cell lines was observed up to 80 and 70% at 156 and 78 μg/ml, respectively. The IC50 value of the extracted SM on KB and A549 cell lines after 24 hours of treatment was seen at 555 and 511 μg/ml, respectively. Conclusion: Due to the good antioxidant and anticancer properties of the isolated Silymarin, its use as an anticancer drug is suggested.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:18 |
|---|---|
| Enthalten in: |
Current drug discovery technologies - 18(2021), 4, Seite 511- |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Azadpour, Mojgan [VerfasserIn] |
|---|
| Links: |
FID Access [lizenzpflichtig] |
|---|
| Umfang: |
1 Online-Ressource (7 p) |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
KFL00896517X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | KFL00896517X | ||
| 003 | DE-627 | ||
| 005 | 20231128151545.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220316s2021 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)KFL00896517X | ||
| 035 | |a (KFL)prod_DARH_.CD7EDC690FC9F9E5A6460DD5A7915CEBE3912096 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 084 | |a PHARM |q DE-84 |2 fid | ||
| 100 | 1 | |a Azadpour, Mojgan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Extraction, Chemical Composition, Antioxidant Property, andIn-vitroAnticancer Activity of Silymarin fromSilybum marianumon Kb and A549 Cell Lines |c Mojgan Azadpour, Mohammad Morad Farajollahi, Ali Mohammad Varzi, Pejman Hashemzadeh, Hossein Mahmoudvand, Mitra Barati |
| 264 | 1 | |c 2021 | |
| 300 | |a 1 Online-Ressource (7 p) | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Introduction: This study aimed to evaluate the antioxidant property of Silymarin (SM) extracted from the seed of Silybum marianum and its anticancer activity on KB and A549 cell lines following 24, 48, and 72 h of treatment. Methods: Ten grams of powdered S. marianum seeds were defatted using n-hexane for 6 hours and then extracted by methanol. The Silymarin extracted of extraction components. The extracted components of Silymarin were measured by spectrophotometric assay and HPLC analysis. 2, 2- diphenyl-1-picrylhydrazyl (DPPH) radical scavenging, phenol content, total flavonoid content, and total antioxidant capacity were measured to detect the antioxidant properties of SM. The anticancer activity of the SM on cell lines evaluated by MTT. Results: In HPLC analysis, more than 50% of the peaks were related to silybin A and B. SM was reduced DPPH (the stable free radical) with a 50% inhibitory concentration (IC50) of 6.56 μg/ ml in comparison with butylated hydroxyl toluene (BHT), which indicated an IC50 of ~3.9 μg/ ml. The cytotoxicity effect of SM on the cell lines was studied by MTT assay. The cytotoxicity effect of the extracted Silymarin on KB and A549 cell lines was observed up to 80 and 70% at 156 and 78 μg/ml, respectively. The IC50 value of the extracted SM on KB and A549 cell lines after 24 hours of treatment was seen at 555 and 511 μg/ml, respectively. Conclusion: Due to the good antioxidant and anticancer properties of the isolated Silymarin, its use as an anticancer drug is suggested | ||
| 700 | 1 | |a Farajollahi, Mohammad Morad |e verfasserin |4 aut | |
| 700 | 1 | |a Varzi, Ali Mohammad |e verfasserin |4 aut | |
| 700 | 1 | |a Hashemzadeh, Pejman |e verfasserin |4 aut | |
| 700 | 1 | |a Mahmoudvand, Hossein |e verfasserin |4 aut | |
| 700 | 1 | |a Barati, Mitra |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current drug discovery technologies |d Hilversum : Bentham Science Publ., 2004 |g 18(2021), 4, Seite 511- |h Online-Ressource |w (DE-627)KFL000006408 |w (DE-600)2133357-9 |w (DE-576)27388834X |x 1875-6220 |7 nnns |
| 773 | 1 | 8 | |g volume:18 |g year:2021 |g number:4 |g pages:511- |
| 856 | 4 | 0 | |u http://pharmazie.proxy.fid-lizenzen.de/fid/bentham-ejournals-pharmazie/www.eurekaselect.com/openurl/content.php?genre=article&issn=1570-1638&volume=18&issue=4&spage=511 |m X:KFL |x Verlag |y FID Access |z lizenzpflichtig |
| 912 | |a ZDB-1-BEJ | ||
| 912 | |a GBV_KFL | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 935 | |i IMPORT_0628_prod_DARH_02 | ||
| 951 | |a AR | ||
| 952 | |d 18 |j 2021 |e 4 |h 511- | ||